OmicsBank
PrivateLast Round
Seed
Aug 25, 2026
Total Funding Raised
$2.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
OmicsBank is a clinical data infrastructure company that provides a platform to standardize and de-identify fragmented clinical and multi-omics data for use in drug development and healthcare AI.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Cloud Infrastructure
Business Model
B2B
Customer Profile
Data as a Service, Revenue Share, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmicsBank Comparables
Compare OmicsBank with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LatchBio | 84% | |
| Elucidata | 80% | |
| Pluto Biosciences | 80% | |
OmicsBank Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 25, 2026 |
OmicsBank Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orbit Ventures | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
$2.25M round led by Redesign Health.
OmicsBank Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OmicsBank's valuation, stock price, and market status.